Literature DB >> 11798589

[Dyslipidaemia and insulin resistance in Chinese in Shanghai].

Y Bao1, W Jia, K Xiang, L Chen, J Lu.   

Abstract

OBJECTIVE: To investigate the impact of dyslipidaemia on insulin resistance in Chinese individuals in Shanghai.
METHODS: 830 individuals aged over 40 years (male 300, female 530) were divided into normal and dyslipidaemia groups. The latter included 7 subgroups as follows: low high density lipoprotein (L-HDL)-subgroup I, high triglycerides (H-TG)-subgroup II, high total cholesterol or high low density lipoprotein (H-TC/H-LDL)-subgroup III, low high density lipoprotein with high triglycerides (L-HDL + H-TG)-subgroup IV, low high density lipoprotein with high total cholesterol or high low density lipoprotein (L-HDL + H-TC/H-LDL)-subgroup V, high triglycerides with high total cholesterol or high low density lipoprotein(H-TG + H-TC/H-LDL)-subgroup VI, low high density lipoprotein with high triglycerides and high total cholesterol or high low density lipoprotein (L-HDL + H-TG + H-TC/H-LDL)-subgroup VII. Homeostasis model assessment (HOMA) was applied to estimate the degree of insulin resistance (IR).
RESULTS: (1) Adjusted with age, sex and body mass index (BMI), HOMA-IR was increased in the dyslipidaemia subgroups with high triglycerides. (2) Hypertriglyceridemia was more closely related to raised BMI and waist-hip ratio (WHR). (3) Both body fat (BMI, WHR) and triglycerides were independent risk factors accounting for HOMA-IR.
CONCLUSION: Hypertriglycerides could be regarded as an independent risk factor for insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11798589

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  1 in total

1.  Association of Insulin Resistance with Glucose and Lipid Metabolism: Ethnic Heterogeneity in Far Western China.

Authors:  Yi-Zhong Yan; Ru-Lin Ma; Jing-Yu Zhang; Jia He; Jiao-Long Ma; Hong-Rui Pang; La-Ti Mu; Yu-Song Ding; Heng Guo; Mei Zhang; Jia-Ming Liu; Dong-Sheng Rui; Kui Wang; Shu-Xia Guo
Journal:  Mediators Inflamm       Date:  2016-12-22       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.